HCV screening strategies targeting prisoners and immigrants from endemic countries: are they cost-effective? (original) (raw)
Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison
Graham Betts-Symonds
International Journal of Drug Policy, 2021
View PDFchevron_right
Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison
Noel Gill
BMC public health, 2006
View PDFchevron_right
Case finding for hepatitis C in primary care: a cost utility analysis
Emanuela Castelnuovo
Family Practice, 2006
View PDFchevron_right
50 is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, the Netherlands Cost-Effective?
Marjolijn van Keep
Journal of Hepatology, 2013
View PDFchevron_right
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study
tony gerard Butler
The Lancet Gastroenterology & Hepatology, 2021
View PDFchevron_right
Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations
Brian Edlin
Value in Health, 2017
View PDFchevron_right
Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
Natasha Martin
View PDFchevron_right
A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia’s prisons
Jake Rance
Harm Reduction Journal, 2018
View PDFchevron_right
A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons
Rhiannon Whitaker
European journal of public health, 2015
View PDFchevron_right
The cost-effectiveness of testing for hepatitis C in former injecting drug users
Emanuela Castelnuovo
Health technology assessment (Winchester, England), 2006
View PDFchevron_right
Cost-effectiveness of targeted screening for hepatitis C in The Netherlands
Andy Hoepelman
Epidemiology and Infection, 2011
View PDFchevron_right
Expanded HIV Testing in Low-Prevalence, High-Income Countries: A Cost-Effectiveness Analysis for the United Kingdom
Sundhiya Mandalia
PLoS ONE, 2014
View PDFchevron_right
Economic evaluation of HCV testing approaches in low and middle income countries
Maria Servidone
BMC Infectious Diseases, 2017
View PDFchevron_right
Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs
J. Leff, Daniel Feaster
View PDFchevron_right
HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations
Andrea Tramarin
Current Pharmaceutical Design, 2008
View PDFchevron_right
Screening for Hepatitis C in injecting drug users: a cost utility analysis
Kim Dalziel
Journal of Public Health, 2004
View PDFchevron_right
Costs of prevention programmes: a comparative analysis of screening campaigns including HCV
catia borriello
Population medicine, 2023
View PDFchevron_right
Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands
Clary van der Veen
International Journal of Drug Policy, 2017
View PDFchevron_right
The testing of people with any risk factor for hepatitis C in community pharmacies is cost‐effective
ryan buchanan
Journal of Viral Hepatitis, 2019
View PDFchevron_right
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA
Roberto Monarca
Journal of Viral Hepatitis
View PDFchevron_right
A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low-to middle-income setting
Abdolreza Fazel
View PDFchevron_right
Development of a Mathematical Model to Estimate the Cost-Effectiveness of HRSA's Ryan White HIV/AIDS Program
Laura Cheever
Journal of Acquired Immune Deficiency Syndromes, 2021
View PDFchevron_right
Assessing the cost-effectiveness of HAART for adults with HIV in England
Alec Miners
Hiv Medicine, 2001
View PDFchevron_right
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort
Giuseppe Foti
Hepatology (Baltimore, Md.), 2017
View PDFchevron_right
Eradicating hepatitis C: Are novel screening strategies for people who inject drugs cost-effective?
francesco manca
International Journal of Drug Policy, 2020
View PDFchevron_right
Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States
Deborah Marshall
View PDFchevron_right
Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)
Jake Rance
Harm Reduction Journal, 2021
View PDFchevron_right
Economic consequences of the implementation of national screening program for chronic HCV infection
Guenka Petrova
Expert Review of Pharmacoeconomics & Outcomes Research, 2019
View PDFchevron_right
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era
Sergio Iannazzo
Alimentary Pharmacology & Therapeutics, 2019
View PDFchevron_right
A cost-consequence analysis of hepatitis B screening in an immigrant population
Alessandra Buja
Annali dell'Istituto superiore di sanità, 2015
View PDFchevron_right
The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden
Hans Gaines
Transfusion, 2010
View PDFchevron_right
The cost-effectiveness of public health interventions
Dominique Bremond
Journal of Public Health, 2011
View PDFchevron_right